NCT03520348View on ClinicalTrials.gov

Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

May 22, 2018

Study Completion Date

July 16, 2018

Conditions
Dry EyeDry Eye Syndrome of Unspecified Lacrimal Gland
Interventions
DRUG

PRO-167

"Dexpanthenol 5%. Ophthalmic gel produced by Laboratorios Sophia, S.A. of C.V., Zapopan, Jalisco, Mexico.~Route of administration: ophthalmic"

DRUG

Corneregel

Dexpanthenol 5%. Ophthalmic gel developed by Bausch and Lomb, Berlin, Germany. Route of administration: ophthalmic

Trial Locations (1)

44200

Centro Oftalmológico San Angel, Guadalajara

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT03520348 - Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects. | Biotech Hunter | Biotech Hunter